Stablepharma Ltd
Stablepharma’s technology platform, StablevaX™ converts existing approved vaccines and therapeutics into fridge free thermostable products.
About Stablepharma Ltd
Stablepharma’s technology platform, StablevaX™ converts existing approved vaccines, therapeutics and diagnostics into fridge free thermostable products that do not require refrigeration to preserve them, thereby addressing the global challenges of the cold chain. Stablepharma’s R&D team have identified up to 60 vaccine candidates that could be suitable for StablevaX™ technology. The company actively collaborates with global vaccine manufacturers, academic institutions and NGOs, to advance their pipeline of thermostable products.
Company Facts
- Headquarters
- Bath
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00011_00050
- Total Funding
- $20,051,433
- Last Funding Type
- grant
- Last Funding Date
- 2025-02-19
- Website
- stablepharma.com
Industries & Categories
Biotechnology, Commercial, Health Care, Impact Investing, Medical Device, Pharmaceutical, Product Research, Wellness
Social Links
Canonical: https://fsome.com/organization/stablepharma-ltd-61283 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.